Order

Size
Price
Stock
Qty

Special Offers

Size
Price
Stock
Qty

LEE 011

 - Ribociclib
Axon 2273
CAS:  1211441-98-3
Purity:  99%
  • Soluble in 0.1N HCl(aq) and DMSO
  • MF:  C23H30N8O
  • MW:  434.54

Description

Orally bioavailable and highly selective small-molecule inhibitor of CDK4/6 (mean IC50 value 307 nM in sensitive neuroblastoma-derived cell lines). LEE011 caused cell-cycle arrest and cellular senescence that was attributed to dose-dependent decreases in phosphorylated RB and FOXM1, respectively. LEE 011 treatment of BE2C and IMR5 neuroblastoma cell lines with demonstrated sensitivity to CDK4/6 inhibition resulted in a dose-dependent accumulation of cells in the G0/G1 phase of the cell cycle.

More Information

Certificate of Analysis

Material Safety Data Sheet

Parent CAS No. 1211441-98-3
Chemical Name 7-cyclopentyl-N,N-dimethyl-2-(5-(piperazin-1-yl)pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide
SMILES C1(NC2=NC=C(N3CCNCC3)C=C2)=NC=C2C=C(C(N(C)C)=O)N(C3CCCC3)C2=N1
MFCD N.A.
InChi InChI=1S/C23H30N8O/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28)
InChiKey RHXHGRAEPCAFML-UHFFFAOYSA-N
CID 44631912
Short Description CDK4/6 inhibitor

Related Products

AXON ID NAME FROM PRICE
1243 NSC 625987

From $104.50

1505 PD0332991 hydrochloride

From $88.00

1530 RO 3306

From $88.00

1539 AT 7519 mesylate

From $88.00

1614 SNS 032

From $93.50

1776 Dinaciclib

From $99.00

1966 AZD5438

From $88.00

1983 R 547

From $104.50

2052 Palbociclib isethionate

From $137.50

2268 XL 413 hydrochloride

From $132.00

2695 NSC 23005 sodium

From $99.00

3184 SR-4835

From $143.00

3228 CDK inhibitor CR8

From $143.00

3402 THZ531

From $143.00

3525 ETP-47799

From $99.00

3535 XY028-140

From $132.00

3693 PF-06873600

From Inquiry

3753 PF-07104091

From $154.00

3762 PF-07220060

From $143.00

3876 OTS-964

From Inquiry

4071 AMG-925

From Inquiry

4097 OTS964 hydrochloride

From $132.00

4265 AZD8421

From Inquiry

Loading...